These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3186370)

  • 1. Medicating children with attention deficit disorder.
    Wiener JM
    Pediatrics; 1988 Nov; 82(5):812. PubMed ID: 3186370
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurogenetic determinism and the new euphenics. Child and adolescent psychiatrists use methylphenidate because it makes children better.
    Williams JH
    BMJ; 1999 May; 318(7196):1488-9. PubMed ID: 10419301
    [No Abstract]   [Full Text] [Related]  

  • 3. Tricyclic antidepressants in the treatment of children with attention deficit disorder.
    Pliszka SR
    J Am Acad Child Adolesc Psychiatry; 1987 Mar; 26(2):127-32. PubMed ID: 3584008
    [No Abstract]   [Full Text] [Related]  

  • 4. [Basics of the drug therapy for attention deficit hyperactivity disorders in adolescents].
    Airaksinen E; Airaksinen MM
    Duodecim; 2003; 119(16):1553-62. PubMed ID: 14535028
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
    Pediatrics; 1987 Nov; 80(5):758-60. PubMed ID: 3670981
    [No Abstract]   [Full Text] [Related]  

  • 7. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hyperactivity in children with pervasive developmental disorders.
    Scahill L; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238
    [No Abstract]   [Full Text] [Related]  

  • 9. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 10. Naturalistic long-term use of methylphenidate in bipolar disorder.
    Lydon E; El-Mallakh RS
    J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results.
    Wigal SB; Wilens TE; Wolraich M; Lerner M
    Pediatrics; 2007 Jul; 120(1):e120-8. PubMed ID: 17548486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R; Gross-Tsur V
    Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
    [No Abstract]   [Full Text] [Related]  

  • 13. Methylphenidate HCl: therapy for attention deficit hyperactivity disorder.
    Capp PK; Pearl PL; Conlon C
    Expert Rev Neurother; 2005 May; 5(3):325-31. PubMed ID: 15938665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial treatments for attention-deficit/hyperactivity disorder in children.
    Barkley RA
    J Clin Psychiatry; 2002; 63 Suppl 12():36-43. PubMed ID: 12562060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism for the efficacy of methylphenidate on attention deficit/hyperactivity disorder and related clinical evidence].
    Okada T
    Seishin Shinkeigaku Zasshi; 2008; 110(10):932-40. PubMed ID: 19278069
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry.
    Teicher MH; Anderson CM; Polcari A; Glod CA; Maas LC; Renshaw PF
    Nat Med; 2000 Apr; 6(4):470-3. PubMed ID: 10742158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder.
    Miller LG; Kraft IA
    Pharmacotherapy; 1994; 14(2):219-23. PubMed ID: 8197043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
    Kalb C
    Newsweek; 2000 Mar; 135(10):53. PubMed ID: 10847892
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Pietrzak RH; Mollica CM; Maruff P; Snyder PJ
    Neurosci Biobehav Rev; 2006; 30(8):1225-45. PubMed ID: 17161238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
    Durukan I; Türkbay T; Cöngöloğlu A
    Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.